QIAseq Multimodal
QIAseq Knowledge Hub

Explore the power of one

One sample, one workflow, multiple insights – all in one day!

Welcome to your one-stop shop for QIAseq Multimodal (RNA + DNA) and Targeted DNA webinars. Save this page to be sure you stay up to date with the latest customer testimonials about how the QIAseq NGS workflows have changed their lab operations.
Recent advances in NGS chemistries, platforms and bioinformatics pipelines have empowered users to efficiently interrogate DNA and RNA modifications in biological samples. Current approaches, however, require the use of two separate workflows to prepare libraries from separate DNA and RNA isolates. This results in duplication of efforts, higher costs and longer turnaround times. In contrast, the revolutionary QIAseq Multimodal portfolio delivers simultaneous DNA and RNA profiling from a single, low-input sample – in just one day.

Lab partner series – Your very own knowledge hub

Learn how our solutions help improve labs operational efficiencies.
  • HRR and HRD: The role of DNA damage repair
    A defective DNA damage repair mechanism is often associated with cancer. Learn how the QIAseq HRD panel can provide deeper insights in homologous recombination deficiency.
    HRR and HRD: The role of DNA damage repair
  • Identification of genetic mutations in HR deficient cancers
    Watch the on-demand webinar with Dr. Nils Hartmann to discover how his lab used a streamlined sample to sequencing workflow to identify genetic mutations in HR deficient breast, ovarian and prostate cancer.
    identify genetic mutations in HR deficient breast, ovarian and prostate cancer
  • Tumor profiling by NGS: Challenges of integrating genomic testing
    View the on-demand webinar presentation where Dr. Pauline Rehal discusses the challenges of the increasing complexity of biomarker testing needs and the hurdles labs will encounter when implementing NGS for precision oncology testing. This webinar also includes a summary of how the QIAseq multimodal portfolio can assist in optimising your labs operational efficiencies and streamline your NGS testing by combining DNA+RNA into a single workflow.
    NGS for precision oncology testing
  • Validating a targeted NGS approach for glioma characterization
    An on-demand webinar recording to learn how using a custom DNA glioma panel, Dr. Michela Bulfoni and her team validates a targeted NGS approach for molecular characterization of glioblastoma and stem cells isolated in four molecular subclasses. By using a single targeted workflow, the lab was able to further improve the results in the molecular definition of gliomas according to WHO classifications.
    custom DNA glioma panel
  • QIAseq Multimodal Panels for lung cancer profiling
    Watch the on-demand webinar where Dr. Sylvia Herold will discuss how her team has streamlined the profiling of lung cancer-associated alterations by using the QIAseq Lung Multimodal Panel – a single workflow for the construction of libraries from total nucleic acids for sequencing on Illumina platforms to achieve high operational efficiency.
    Multimodal Panels
  • Evaluation of QIAseq Multimodal Panel in comprehensive genomic profiling (CGP)
    Recent advancements in NGS workflows enable the profiling of the genomic alterations but at the cost of requiring parallel workflow for library construction from DNA and RNA inputs. The need for parallel workflows results in duplication of efforts, higher costs and longer turnaround times. In this webinar, Dr. Ravi Kolhe will share his insights on using the QIAseq Pan-cancer Multimodal Panel for comprehensive genomic profiling to streamline the analysis of cancer-associated alterations by using a single workflow to achieve high operational efficiency.
    Dr. Ravi Kolhe
  • HRR and HRD: The role of DNA damage repair
    HRR and HRD: The role of DNA damage repair
  • identify genetic mutations in HR deficient breast, ovarian and prostate cancer
    Identification of genetic mutations in HR deficient cancers
  • NGS for precision oncology testing
    Tumor profiling by NGS: Challenges of integrating genomic testing
  • custom DNA glioma panel
    Validating a targeted NGS approach for glioma characterization
  • Multimodal Panels
    QIAseq Multimodal Panels for lung cancer profiling
  • Dr. Ravi Kolhe
    Evaluation of QIAseq Multimodal Panel in comprehensive genomic profiling (CGP)
Want to streamline your NGS workflow to improve your labs operational efficiencies?
Use our single extraction QIAseq Multimodal Panels.
QIAseq Multimodal Panels are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease. For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor.